Bonesupport Holding AB (publ) (STO: BONEX)

Market Cap	25.14B
Revenue (ttm)	814.46M
Net Income (ttm)	90.58M
Shares Out	65.81M
EPS (ttm)	1.38
PE Ratio	277.53
Forward PE	96.53
Dividend	n/a
Ex-Dividend Date	n/a

Volume	362,931
Open	380.40
Previous Close	380.40
Day's Range	362.60 - 384.20
52-Week Range	172.50 - 384.40
Beta	1.01
Analysts	n/a
Price Target	n/a
Earnings Date	Feb 25, 2025

About Bonesupport Holding AB

Bonesupport Holding AB (publ), an orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally. The company provides CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; CERAMENT V, an injectable ceramic bone graft sub...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1999
• Employees: 118
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: BONEX